Rk | Athlete | FGMPG |
FGAPG |
FGPCT |
3PMPG |
3PAPG |
3PPCT |
eFGPCT |
FTMPG |
FTAPG |
FTPCT |
---|---|---|---|---|---|---|---|---|---|---|---|
1 |
Collins-Maxwell |
5.2 | 13.4 | 38.6% | 1.9 | 6.0 | 32.1% | 45.8% | 0.8 | 1.5 | 52.9% |
2 |
Collins-Maxwell |
2.4 | 8.5 | 28.1% | 1.2 | 5.3 | 23.0% | 35.2% | 1.0 | 1.9 | 52.3% |
3 |
Collins-Maxwell |
3.7 | 10.7 | 34.8% | 1.5 | 5.3 | 28.1% | 41.7% | 1.3 | 1.9 | 67.4% |
4 |
Collins-Maxwell |
2.3 | 6.2 | 37.1% | 1.0 | 3.6 | 29.3% | 45.5% | 0.7 | 1.3 | 48.4% |
5 |
BCLUW |
5.0 | 13.1 | 38.3% | 1.1 | 4.3 | 25.9% | 42.5% | 3.0 | 4.3 | 70.4% |
6 |
Colo-Nesco |
3.6 | 8.8 | 41.2% | 0.9 | 3.5 | 24.7% | 46.1% | 1.7 | 3.7 | 45.7% |
7 |
Baxter |
8.5 | 15.9 | 53.9% | 0.9 | 3.0 | 30.8% | 56.7% | 1.8 | 2.8 | 64.5% |
8 |
GMG |
1.3 | 3.6 | 36.7% | 0.6 | 2.2 | 28.6% | 45.6% | 0.0 | 0.0 | 0.0% |
9 |
Baxter |
1.2 | 2.9 | 40.4% | 0.8 | 2.2 | 34.9% | 53.5% | 0.2 | 0.4 | 37.5% |
10 |
Baxter |
5.1 | 9.9 | 51.4% | 0.5 | 1.8 | 27.0% | 53.8% | 2.1 | 3.1 | 68.2% |
11 |
BCLUW |
1.0 | 3.2 | 29.7% | 0.4 | 1.5 | 23.3% | 35.2% | 0.3 | 0.7 | 46.2% |
12 |
North Tama |
2.8 | 7.4 | 37.8% | 0.1 | 1.0 | 9.1% | 38.5% | 0.9 | 1.9 | 47.5% |
13 |
North Tama |
3.7 | 7.2 | 50.7% | 0.3 | 1.0 | 31.6% | 52.8% | 1.5 | 3.5 | 42.9% |
13 |
Baxter |
2.2 | 5.5 | 39.3% | 0.2 | 0.9 | 26.3% | 41.4% | 1.4 | 1.8 | 76.9% |
15 |
GMG |
2.3 | 6.0 | 38.0% | 0.0 | 0.4 | 0.0% | 38.0% | 1.0 | 1.5 | 66.7% |
16 |
GMG |
1.3 | 2.5 | 50.0% | 0.8 | 1.5 | 50.0% | 65.0% | 0.0 | 0.3 | 0.0% |
16 |
Colo-Nesco |
0.3 | 1.5 | 22.2% | 0.2 | 1.0 | 16.7% | 27.8% | 0.2 | 0.3 | 50.0% |
18 |
GMG |
0.2 | 0.8 | 29.4% | 0.0 | 0.1 | 33.3% | 32.4% | 0.0 | 0.1 | 0.0% |
18 |
Baxter |
5.0 | 7.9 | 63.2% | 0.0 | 0.1 | 0.0% | 63.2% | 1.6 | 2.4 | 66.0% |
20 |
GMG |
4.0 | 8.0 | 49.7% | 0.0 | 0.0 | 0.0% | 49.7% | 0.5 | 1.3 | 35.7% |
20 |
Colo-Nesco |
1.7 | 3.7 | 44.8% | 0.0 | 0.1 | 0.0% | 44.8% | 0.3 | 0.9 | 35.3% |
20 |
Collins-Maxwell |
0.3 | 1.0 | 30.8% | 0.0 | 0.1 | 0.0% | 30.8% | 0.1 | 0.2 | 50.0% |